Conditions

New study suggests that in hospital patients with T2DM, premixed insulin provides similar glycemic control as a basal-bolus insulin regimen.

The FDA is requiring the drug company to submit more clinical data.

Blood group also possible indicator of development of gestational diabetes itself.

New research shows similar response in seniors with diabetes as those without.

Findings suggest treatment may reduce urine albumin creatinine ratio in T1DM.

Findings show longer relationships and longer consultations between prescribing nurses and diabetic patients.

Combination does not alter myocardial infarction, hospitalization risks.

Diabetes in Control publisher Steve Freed meets with Dr. Larry Hirsch, Vice President of Global Medical Affairs for the Diabetes Care Business at BD at the 2015 ADA Sessions in Boston. Dr. Hirsch talks about the work toward improving patient experience when taking injections and the results of a study on the nano needle use in obese patients.

People with the genetic variant MTNR1B may be at a greater risk.

Improved metabolic function and induced moderate weight loss observed.